TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
Report Overview ‘OPKO Health, Inc. - Product Pipeline Review - 2016’, provides an overview of the OPKO Health, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by OPKO Health, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Read More At: http://www.researchbeam.com/leo-pharma-as-product-pipeline-review-2016-market
Report Overview Scope • The report provides a snapshot of the pipeline therapeutic landscape of OPKO Health, Inc. • The report provides overview of OPKO Health, Inc. including its business description, key facts, and locations and subsidiaries • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages • The report features OPKO Health, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy • Evaluate OPKO Health, Inc.’s strategic position with total access to detailed information on its product pipeline • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies • Identify potential new clients or partners in the target demographic • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Read More At: http://www.researchbeam.com/opko-health-inc-product-pipeline-review-2016-market
Table of Content List of Tables OPKO Health, Inc., Key Information 7 OPKO Health, Inc., Key Facts 7 OPKO Health, Inc. - Pipeline by Indication, 2016 9 OPKO Health, Inc. - Pipeline by Stage of Development, 2016 11 OPKO Health, Inc. - Monotherapy Products in Pipeline, 2016 12 OPKO Health, Inc. - Combination Treatment Modalities in Pipeline, 2016 13 OPKO Health, Inc. - Out-Licensed Products in Pipeline, 2016 14 OPKO Health, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 15 OPKO Health, Inc. - Filing rejected/Withdrawn, 2016 16 OPKO Health, Inc. - Unknown, 2016 22 OPKO Health, Inc. - Pipeline by Target, 2016 55 OPKO Health, Inc. - Pipeline by Route of Administration, 2016 57 OPKO Health, Inc. - Pipeline by Molecule Type, 2016 58 OPKO Health, Inc. - Pipeline Products by Mechanism of Action, 2016 60 OPKO Health, Inc. - Recent Pipeline Updates, 2016 61 OPKO Health, Inc. - Dormant Developmental Projects,2016 76 OPKO Health, Inc., Subsidiaries 78 Enquire More At: http://www.researchbeam.com/opko-health-inc-product-pipeline-review-2016market/enquire-about-report
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/opko-health-inc-productpipeline-review-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States